Skip to content
CancerIndex

Publication

Response to ERBB3-Directed Targeted Therapy in NRG1-Rearranged Cancers.

Authors not recorded

Cancer Discov2018PMID 29610121PMC5984717stubpubmedProvenance
Source
PubMed
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-CIVIC-20260908-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

Data not yet available

No abstract stored. Read on PubMed

Linked entities

Linked entities (3)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Validated 3

Curated evidence

Evidence citing this paper (2)

civicProvenance
Source
CIViC — Clinical Interpretation of Variants in Cancer
Dataset
CIViC evidence items
Version
civic-2026-09-08
Retrieved
Sep 8, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Evidence
expert curation
License
CC0 1.0
PMID
29610121
Run
ING-CIVIC-20260908-000001
Open at source
CuratedShowing 1–2 of 2 evidence items · levels, directions and significance as curated at the source; each row links to its CIViC record.
TherapyCancerTypeLevelDirection · significanceRating (1–5)StatusEvidenceSource
NRG1 Fusion2
AfatinibMucinous Lung AdenocarcinomaUNRESOLVEDPredictiveCDoes Not Support Sensitivity Response3accepted
EID6096

One patient with an NRG1-rearranged invasive mucinous adenocarcinomas (IMAs) of the lung had a response with an anti-ERBB3 monoclonal antibody (GSK2849330). No response was achieved with afatinib in f… (full text at CIViC)

PMID 29610121 · Drilon et al., 2018 · Open in CIViC

civic
Anti-HER3 Monoclonal Antibody GSK2849330Mucinous Lung AdenocarcinomaUNRESOLVEDPredictiveCSupports Sensitivity Response3submitted
EID6095

One patient with an NRG1-rearranged invasive mucinous adenocarcinomas (IMAs) of the lung had a response with an anti-ERBB3 monoclonal antibody (GSK2849330). No response was achieved with afatinib in f… (full text at CIViC)

PMID 29610121 · Drilon et al., 2018 · Open in CIViC

civic